Previously, there was a significant history of tobacco-funded researchers failing to disclose their conflicts of interest. By now doing the same thing, we are blurring the distinction. Now, the public is going to question the integrity of our research, not just that conducted by or supported by the tobacco companies.

Thanks to deception like that we see here from Dr. Fiore, there is a perception that the use of smoking cessation drugs is the "standard of care." This is far from the truth. If the public, and tobacco practitioners themselves, understood the depth of the connection between those who crafted the "standard of care" (i.e., the Clinical Practice Guideline recommendations) and the industry that manufactures the drugs that are recommended in the Guideline, it would become apparent that these recommendations are heavily biased, not objective, and inappropriate.

This advice is all fine and dandy for smokers who feel confident that they can quit using FDA-approved drugs. However, what about smokers who don't have the self-efficacy to quit using such drugs? What about smokers who have tried and failed with these approaches and are quite sure that it would be a waste of time to try the same dismal methods again? And what about smokers who are particularly excited about the possibility of using electronic cigarettes in a quit attempt?

LAST：2014 aspire Aspire ET-S BDC Glassomizer glass bottle atomizer |NEXT：High quality LED display voltage E cig ego vv with CE4+ CE5 CE6 Atomizer